Skip to content

Myriad Genetics MYGN Finance Lease, Principal Payments

Finance Lease, Principal Payments at other companies

Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
GeneDx Holdings logo
GeneDx HoldingsWGS
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
Castle Biosciences logo
Castle BiosciencesCSTL
Azenta logo
AzentaAZTA

Other financials

Income statement

See full
Revenue$200.4M+2.3%
Gross profit$137.6M+2.5%
Operating income-$30.7M-5.9%
Net income-$34.1M-34,000%
EPS (diluted)-$0.36

Balance sheet

See full
Cash & equivalents$126.0M+24.8%
Total debt$211.5M+34.2%
Total equity$337.4M-52.1%
Total assets$673.7M-33.0%

Cash flow

See full
Operating cash flow-$15.7M+3.7%
CapEx$18.8M+181%
Free cash flow-$19.7M+65.1%

Valuation

See full
Market cap$512.85M+13.1%
Enterprise value$598.35M+17.3%
P/S0.6×+0.1×

Profitability

See full
Gross margin70%0.0pp
Operating margin-46.9%-88.3pp
Net margin-48.2%-72.9pp
FCF margin-17%

Returns & leverage

See full
Return on equity-76.7%-98.4pp
Debt / equity0.6×+0.4×
Current ratio2.4×+0.5×

Where this comes from

Reported directly by Myriad Genetics in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeasePrincipalPayments.

The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Myriad Genetics's finance lease, principal payments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Myriad Genetics's finance lease, principal payments?
Myriad Genetics (MYGN) reported finance lease, principal payments of $100K in Q1 2026.
How has Myriad Genetics's finance lease, principal payments changed year-over-year?
Myriad Genetics's finance lease, principal payments decreased by 0.0% year-over-year, from $100K to $100K.